Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms - Takeaways - MDSpire

Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms

  • By

  • Christoph J Auernhammer

  • Katharina Wang

  • Umberto Maccio

  • Thomas Knösel

  • Maximilian P Hungbauer

  • Katharina Schilbach

  • Julian Maurer

  • Lea Peischer

  • Astrid Reul

  • Elena Kuzmenko

  • Edlira Luca

  • Julia Hamati

  • Diana Vetter

  • Jose Oberholzer

  • Ralph Fritsch

  • Karel Pacak

  • Ashley B Grossman

  • Felix Beuschlein

  • Martin Reincke

  • Constanze Hantel

  • Kathrin Zitzmann

  • Svenja Nölting

  • January 10, 2026

  • 0 min

Share

  • 1

    A standardized platform for personalized drug screening in GEP-NENs was established using patient-derived primary cultures.

  • 2

    The study evaluated 27 agents, including targeted therapies and chemotherapeutics, for their efficacy on GEP-NEN primary cultures.

  • 3

    Significant differences in drug response were identified between pancreatic NETs and small intestinal NETs.

  • 4

    The 5-year survival rates for metastatic GEP-NETs and GEP-NECs are notably low, highlighting the need for innovative therapies.

  • 5

    This research aims to enhance personalized treatment decisions for patients with rare gastroenteropancreatic neuroendocrine tumors.

Original Source(s)

Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms

  • by Christoph J Auernhammer, Katharina Wang, Umberto Maccio, Thomas Knösel, Maximilian P Hungbauer, Katharina Schilbach, Julian Maurer, Lea Peischer, Astrid Reul, Elena Kuzmenko, Edlira Luca, Julia Hamati, Diana Vetter, Jose Oberholzer, Ralph Fritsch, Karel Pacak, Ashley B Grossman, Felix Beuschlein, Martin Reincke, Constanze Hantel, Kathrin Zitzmann, Svenja Nölting

  • January 10, 2026

Related Content

MicroRNAs in cancer: biogenesis, biomarkers and therapeutic strategies

Adrenal cortical adenoma-cavernous hemangioma collision tumor: a case report

Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic